新华制药(000756) - 2015 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2015 was ¥999,523,085.35, representing a 6.76% increase compared to ¥936,219,080.78 in the same period last year[8] - Net profit attributable to shareholders was ¥14,259,441.26, a significant increase of 341.84% from ¥3,227,315.98 in the previous year[8] - The net profit after deducting non-recurring gains and losses was ¥12,919,419.71, up 166.96% from ¥4,839,374.23 year-on-year[8] - The total profit for the first quarter of 2015 was RMB 20,902 thousand, representing a growth of 100.33% compared to the same period last year[17] - Net profit attributable to the parent company for the first quarter of 2015 reached RMB 14,259 thousand, a significant increase of 341.84% year-on-year, driven by price increases and reduced raw material consumption[18] Cash Flow - The net cash flow from operating activities was negative at -¥18,147,578.63, a decline of 128.95% compared to ¥62,682,762.70 in the same period last year[8] - The net cash flow from operating activities for the first quarter of 2015 was RMB -18,148 thousand, a decrease of RMB 80,830 thousand compared to the previous year, mainly due to an increase in accounts receivable[18] - The company reported a net cash flow from financing activities of RMB 14,853 thousand for the first quarter of 2015, an increase of RMB 124,397 thousand year-on-year, due to reduced bank loan repayments[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 39,284[11] - The largest shareholder, Shandong Xinhua Pharmaceutical Group Co., Ltd., held 34.67% of the shares, amounting to 158,555,763 shares[11] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,349,056,228.98, reflecting a 2.45% increase from ¥4,245,149,713.77 at the end of the previous year[8] - The net assets attributable to shareholders were ¥1,838,921,894.75, which is a 1.00% increase from ¥1,820,690,172.44 at the end of the previous year[8] - As of March 31, 2015, accounts receivable increased by 56.63% year-on-year to RMB 488,621 thousand, primarily due to the payment terms of certain sales not yet being due[16] Expenses - The net cash flow from operating activities was negative at -¥18,147,578.63, a decline of 128.95% compared to ¥62,682,762.70 in the same period last year[8] - The financial expenses for the first quarter of 2015 rose by 56.79% year-on-year to RMB 19,991 thousand, attributed to changes in loan scale and interest rates[16] - The company's sales expenses for the first quarter of 2015 increased by 31.42% year-on-year to RMB 111,955 thousand, driven by higher market development and terminal sales costs[16] - The total tax expenses for the first quarter of 2015 increased by 66.59% year-on-year to RMB 4,099 thousand, reflecting higher profitability[18] Investment Income - Investment income for the first quarter of 2015 decreased by 53.03% year-on-year to RMB 223 thousand, mainly due to a reduction in structured deposit amounts compared to the previous year[16] Earnings Per Share - Basic and diluted earnings per share increased to ¥0.03, a 200% rise from ¥0.01 in the previous year[8] - The weighted average return on equity rose to 0.78%, an increase of 0.60 percentage points from 0.18% in the previous year[8]